Infective Endocarditis empiric therapies Flashcards
Native valve; highly susceptible strep
name AND dose AND DoT for all
PCN-G 18M units/24h +/- 2 week course of gentimicin
DoT: 2-4 weeks
Prosthetic valve; high susceptible strep
PCN-G 24M units/24h + mandatory 2 week course of gentimicin
DoT: 6 weeks
Native valve; relatively resistant strep
PCN-G 24M units/24h + mandatory 2 week course of gentimicin
DoT: 4 weeks
Prosthetic valve; relatively resistant strep
PCN-G 24M units/24h + mandatory 6 week course of gentimicin
DoT: 6 weeks
Native valve; highly resistant strep
ampicillin 12g/24h OR PCN-G 18-30M units/24h + 4-6 weeks of ceftriaxone OR gentimicin
DoT: 4-6 weeks
Native valve; Enterococci (susceptible)
ampicillin 12g/24h OR PCN-G 18-30M units/24h + 4-6 weeks of ceftriaxone OR gentimicin
DoT: 4-6 weeks
Prosthetic valve; highly resistant strep
ampicillin 12g/24h OR PCN-G 18-30M units/24h + 4-6 weeks of ceftriaxone OR gentimicin
DoT: 6 weeks
Prosthetic valve; Enterococci (susceptible)
ampicillin 12g/24h OR PCN-G 18-30M units/24h + 4-6 weeks of ceftriaxone OR gentimicin
DoT: 6 weeks
Enterococci (beta-lactam resistant)
linezolid, synercid, daptomycin
DoT: 8 weeks
Native valve; MSSA
nafcillin 12g/24h OR cefazolin
DoT: 6 weeks
Prosthetic valve; MSSA
nafcillin +rifampin+ gentimicin(2 weeks)
DoT: 6-8 weeks
Native valve; MRSA
vancomycin OR daptomycin
DoT: 6 weeks
Prosthetic valve; MRSA
vancomycin+rifampin+gentimicin (2 weeks)
DoT: 6-8 weeks
HACEK (for both valve types)
ceftriaxone or unasyn
DoT: 4 weeks